پارس دارو

دپارس | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 62,110 2.98
Close Price: 61,750

Financial Ratios

2026/08/16
Fiscal Year 2026/03/2012 Month
2026/08/11
Fiscal Year 2026/03/2012 Month
2026/07/02
Fiscal Year 2026/03/2012 Month

Net Profit to Sales

48.33--

Gross Profit to Sales

54.41--

Operating Margin

55.97--

Gross Profit to Sales

39.64--

Net Profit to Gross Profit

121.93--

Return on Assets (ROA)

27.75--

Return on Capital (%)

475.5--

Return on Equity (ROE)

66.42--

Working Capital Return

70.94--

Fixed Asset Return

710.72--

Loan Benefit Assessment

2.39--

Current Ratio

1.711.711.76

Quick Ratio

1.511.511.66

Liquidity Ratio

000.01

Net Working Capital

16,421,18816,421,18816,035,627

Current Assets Ratio

0.940.940.94

Inventory Turnover

101.41--

Receivables Collection Period

500.64--

Inventory to Working Capital

0.280.280.13

Working Capital Turnover

1.47--

Fixed Asset Turnover

14.71--

Total Asset Turnover

0.57--

Debt Ratio

0.580.580.57

Debt to Equity

1.391.391.33

Long-Term Debt to Equity

0.080.080.08

Current Debt to Equity

1.311.311.24

Equity Ratio

41.7841.7843.01

Debt Coverage Ratio

1.161.160.99